IRIS
MINISINI, Rosalba
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.336
NA - Nord America 2.633
AS - Asia 2.002
SA - Sud America 339
AF - Africa 76
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 1
Totale 8.397
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.542
SG - Singapore 763
IE - Irlanda 750
IT - Italia 680
DE - Germania 473
CN - Cina 347
HK - Hong Kong 340
SE - Svezia 316
BR - Brasile 274
RU - Federazione Russa 223
UA - Ucraina 217
FR - Francia 194
IN - India 161
VN - Vietnam 151
FI - Finlandia 144
CZ - Repubblica Ceca 94
GB - Regno Unito 85
KR - Corea 74
CA - Canada 56
ID - Indonesia 52
BJ - Benin 44
AT - Austria 34
PL - Polonia 31
TR - Turchia 28
ES - Italia 26
MX - Messico 25
NL - Olanda 23
AR - Argentina 20
BE - Belgio 19
BD - Bangladesh 16
IR - Iran 16
JP - Giappone 15
ZA - Sudafrica 15
EC - Ecuador 14
LT - Lituania 9
EU - Europa 8
CO - Colombia 7
IQ - Iraq 7
CL - Cile 6
VE - Venezuela 6
KE - Kenya 5
PY - Paraguay 5
UZ - Uzbekistan 5
EG - Egitto 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
IL - Israele 3
JM - Giamaica 3
PE - Perù 3
PK - Pakistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
DZ - Algeria 2
GT - Guatemala 2
KZ - Kazakistan 2
MA - Marocco 2
NP - Nepal 2
PA - Panama 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GI - Gibilterra 1
HU - Ungheria 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
PH - Filippine 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
YT - Mayotte 1
Totale 8.397
Salva come PNG Salva come JPEG
Città #
Dublin 738
Jacksonville 368
Hong Kong 339
Singapore 223
Ashburn 206
Dearborn 182
Beijing 177
Novara 139
Chandler 132
Los Angeles 100
Piemonte 97
Milan 89
Wilmington 87
Moscow 84
Lawrence 81
Princeton 81
Munich 79
Seoul 68
Ann Arbor 67
San Mateo 59
Buffalo 57
Turin 52
New York 48
Ho Chi Minh City 46
São Paulo 45
Cotonou 44
Jakarta 41
Andover 38
Vercelli 38
Brno 35
Nuremberg 34
Pardubice 34
Hanoi 33
Frankfurt am Main 28
Helsinki 27
Boardman 25
Denver 25
Brooklyn 24
Warsaw 23
Chennai 22
Dallas 22
London 22
Santa Clara 22
Bremen 21
Brussels 19
Nanjing 19
Turku 19
Houston 18
Falkenstein 17
Montreal 17
Poplar 17
Düsseldorf 16
Amsterdam 15
Atlanta 15
Stockholm 15
Toronto 15
Tokyo 14
České Budějovice 14
Chicago 13
Orem 12
Redondo Beach 12
Vienna 12
Johannesburg 11
Mexico City 11
Seattle 11
Dong Ket 10
Mülheim 10
Biên Hòa 9
Bologna 9
Brescia 9
Cassano Magnago 9
Jinan 9
Mumbai 9
Norwalk 9
Ottawa 9
Phoenix 9
Ankara 8
Boston 8
Charlotte 8
New Delhi 8
Stankov 8
West Jordan 8
Curitiba 7
Guayaquil 7
Hefei 7
Manchester 7
Palermo 7
Rome 7
Tianjin 7
Assago 6
Augusta 6
Brasília 6
Fairfield 6
Kunming 6
Porto Alegre 6
Roubaix 6
Salvador 6
Strasbourg 6
Alessandria 5
Bexley 5
Totale 4.776
Salva come PNG Salva come JPEG
Nome #
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 207
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease 135
rs1801253 Gly/Gly carriage in the ADRB1 gene leads to unbalanced cardiac sympathetic modulation as assessed by spectral analysis of heart rate variability 131
Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy interplay. 129
Japanese encephalitis virus RNA detected in Culex pipiens mosquitoes in Italy 124
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 122
Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma 121
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 119
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 116
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 114
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 110
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 108
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein 108
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients 107
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 104
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 102
Influence of age on sex-related differences among patients with hepatitis C. 101
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 100
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 100
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 99
17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle 98
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 95
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 95
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 95
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 93
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 93
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 92
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 90
Gas6 as a putative noninvasive biomarker of hepatic fibrosis 90
Understanding protection from SARS-CoV-2 using metabolomics 90
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 90
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 89
Recent advances in HCV entry 89
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 89
ACE genotype, body weight changes and target organ damage in renal transplant recipients 89
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 88
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 88
Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C 87
Severity of nonalcoholic fatty liver disease in type 2 diabetes mellitus: Relationship between nongenetic factors and PNPLA3/HSD17B13 polymorphisms 87
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 87
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 85
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 85
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 85
Carriage of the apolipoprotein E-epsilon4 allele and histologic outcome of recurrent hepatitis C after antiviral treatment 85
L’impatto del Long COVID è stato minore nella terza ondata della pandemia rispetto alla prima ondata in una popolazione italiana di 324 pazienti. 84
Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients 84
Can apical ballooning cardiomyopathy and anterior STEMI be differentiated based on β1 and β2-adrenergic receptors polymorphisms? 84
Interferon-stimulated gene pathways in the treatment of viral hepatitis 82
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 82
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 81
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E epsilon4 carriers: relationship with the blood lipid profile 81
Modulation of Oxidative Stress by 17 β-Estradiol and Genistein in Human Hepatic Cell Lines In Vitro 80
Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections 79
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP 78
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 77
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 76
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. 75
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 73
INTERLEUKIN 6 PROMOTER POLYMORPHISMS INFLUENCE THE OUTCOME OF CHRONIC HEPATITIS C 73
Hepatitis B virus and lymphomagenesis: novel insights into an occult relationship 72
Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome 71
Circadian control of hepatitis B virus replication 71
Unsuspected strongyloidiasis in hospitalized elderly patients with and without eosinophilia 70
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 69
Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment 68
COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters 67
GENETIC POLYMORPHISM AT THE APOLIPOPROTEIN E LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B 66
Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C 65
Reference values of one-point carotid stiffness parameters determined by carotid echo-tracking and brachial pulse pressure in a large population of healthy subjects 65
Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study 65
T-cell mediated responses against alpha-foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival 65
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 64
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients 64
Evaluation of donor hepatic iron concentration as a factor of early fibrotic progression after liver transplantation 64
TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer 63
Robust and persistent b-and t-cell responses after covid-19 in immunocompetent and solid organ transplant recipient patients 63
Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease 62
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 62
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 61
Role of Interleukin 28B rs12979860 C/T Polymorphism on the Histological Outcome of Chronic Hepatitis C: Relationship with Gender and Viral Genotype 59
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 58
Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C 57
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 57
INTERLEUKIN-6 POLYMORPHISMS AND GENDER: RELATIONSHIP WITH THE OCCURRENCE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH END-STAGE LIVER DISEASE 56
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis 56
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC 55
Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis 55
Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression 55
Pegylated Vs. conventional interferon–alpha in antiviral regimens for recurrent hepatitis C: a comparison of tolerability and efficacy 54
Prevalence and clinical relevance of occult hepatitis B virus infection in patients on the waiting list for kidney transplantation 54
GENDER-RELATED DISTRIBUTION OF THE INTERLEUKIN-1BETA AND INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE POLYMORPHISMS IN PATIENTS WITH END-STAGE LIVER DISEASE 54
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma 54
Inflammatory and Immune Responses during SARS-CoV-2 Infection in Vaccinated and Non-Vaccinated Pregnant Women and Their Newborns 53
Identification of a Functional, CRM-1-Dependent Nuclear Export Signal in Hepatitis C Virus Core Protein 53
Prevalence and risk factors for delayed adrenal insufficiency after liver transplantation. Liver Transpl. 2008 Jul;14(7):1014-9 53
Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study 52
MTHFR C677T Polymorphism and Risk of HCC in Patients With Liver Cirrhosis: Role of Male Gender and Alcohol Consumption 52
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 52
Weight gain after liver transplantation and the I/D polymorphism of the angiotensin-converting enzyme gene 52
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 50
Totale 8.158
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.871
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.871
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021293 0 0 0 0 0 32 74 6 75 15 77 14
2021/2022535 11 23 80 39 29 0 46 19 43 40 81 124
2022/20231.513 153 74 84 16 69 116 59 52 762 13 81 34
2023/2024919 54 108 51 25 152 39 186 29 23 43 68 141
2024/20251.687 41 30 91 33 55 91 188 164 341 120 153 380
2025/20262.183 265 215 301 750 607 45 0 0 0 0 0 0
Totale 8.605